Dinglan Wu

7PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 03, 2026
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.

Jiayi Zhou, Yinggui Yang, Ran Ye

|Oct 18, 2025
Neuroscience in prostate cancer.

Ziteng Liu, Qiang Peng, Yuliang Wang

|Sep 25, 2024
Nuclear receptor TLX functions to promote cancer stemness and EMT in prostate cancer via its direct transactivation of CD44 and stem cell-regulatory transcription factors.

Sin Ting Chow, Jiaqi Fan, Xingxing Zhang

|Apr 22, 2024
Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein-Barr virus entry into epithelial cells.

Yinggui Yang, Tengteng Ding, Ying Cong

|Jan 21, 2023
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.

Pengyu Liu, Wenxuan Wang, Fei Wang

|Oct 17, 2022
Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer.

Wenxuan Wang, Qinghui Wu, Ali Mohyeddin

Pageof 2

Frequent Collaborators

2 joint publications

Chi-Fai Ng

1 joint publications

Wenxuan Wang

1 joint publications

Qinghui Wu

1 joint publications

Ali Mohyeddin